Search for: "Teva USA" Results 481 - 500 of 714
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Feb 2014, 8:36 am by m zamora
– topical gel applied to the skinAxiron (Lilly USA, LLC) – topical cream applied to underarmBio-T-Gel (Teva Pharmaceuticals) – topical gel applied to skinDelatestryl (Endo Pharmaceuticals) – injection or solutionDepo-Testosterone (Unigen Life Sciences) – injection solutionFortesta (Endo Pharmaceuticals) – topical gel applied to skinStriant (Auxilium Pharmaceuticals) – buccal tablet absorbed through the… [read post]
8 Mar 2017, 8:03 pm by Lawrence B. Ebert
Because we see no error in these rulings, we affirmthe district court’s entry of judgment against Sprint.Teva gets cited as to "claim construction":The proper construction of a patent’s claims is an issueof Federal Circuit law, and we apply the frameworkset forth in Teva Pharmaceuticals USA, Inc. v. [read post]
17 Jul 2009, 1:43 am
Teva Pharmaceuticals USA Inc.INTELLECTUAL PROPERTY - Patents"In granting Eisai's motion to strike in this patent infringement case, the judge erred where she misapplied Rule 9(b) and it cannot be held as a matter of law that Teva's allegations have no possible relation to its defense". [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape… [read post]
29 Apr 2014, 1:39 pm by Barry Barnett
The Supreme Court today granted certiorari in Teva Pharmaceuticals USA, Inc. v. [read post]
20 Sep 2011, 6:35 am by Bexis
Teva Pharmaceuticals USA, Inc., 2011 WL 4025734 (S.D. [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy': (IP… [read post]